GEN vs PPCB · P/E 17, rev $5.00B vs P/E 0.0, $3.9M cap
Gen Digital Inc. (GEN) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
PPCB does not have a complete income-statement cache yet.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the GEN and PPCB stock pages for the full models.
Not investment advice.